|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 8238 |
FusionGeneSummary for CPE_ARHGEF4 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CPE_ARHGEF4 | Fusion gene ID: 8238 | Hgene | Tgene | Gene symbol | CPE | ARHGEF4 | Gene ID | 1363 | 50649 |
| Gene name | carboxypeptidase E | Rho guanine nucleotide exchange factor 4 | |
| Synonyms | CPH | ASEF|ASEF1|GEF4|STM6 | |
| Cytomap | 4q32.3 | 2q21.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | carboxypeptidase Ecarboxypeptidase Hcobalt-stimulated chromaffin granule carboxypeptidaseenkephalin convertaseinsulin granule-associated carboxypeptidaseprohormone-processing carboxypeptidase | rho guanine nucleotide exchange factor 4APC-stimulated guanine nucleotide exchange factor 1Rho guanine nucleotide exchange factor (GEF) 4 | |
| Modification date | 20180527 | 20180519 | |
| UniProtAcc | P16870 | Q9NR80 | |
| Ensembl transtripts involved in fusion gene | ENST00000402744, | ENST00000409359, ENST00000326016, ENST00000392953, ENST00000428230, ENST00000525839, ENST00000409303, ENST00000355771, ENST00000439368, | |
| Fusion gene scores | * DoF score | 5 X 4 X 4=80 | 3 X 2 X 3=18 |
| # samples | 5 | 3 | |
| ** MAII score | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: CPE [Title/Abstract] AND ARHGEF4 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CPE | GO:0016055 | Wnt signaling pathway | 22824791 |
| Hgene | CPE | GO:0072657 | protein localization to membrane | 19166515 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | LGG | TCGA-FG-7643-01A | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000402744 | ENST00000409359 | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
| Frame-shift | ENST00000402744 | ENST00000326016 | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
| Frame-shift | ENST00000402744 | ENST00000392953 | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
| 5CDS-intron | ENST00000402744 | ENST00000428230 | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
| 5CDS-intron | ENST00000402744 | ENST00000525839 | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
| 5CDS-intron | ENST00000402744 | ENST00000409303 | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
| 5CDS-intron | ENST00000402744 | ENST00000355771 | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
| 5CDS-intron | ENST00000402744 | ENST00000439368 | CPE | chr4 | 166419472 | + | ARHGEF4 | chr2 | 131674224 | + |
Top |
FusionProtFeatures for CPE_ARHGEF4 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CPE | ARHGEF4 |
| Removes residual C-terminal Arg or Lys remaining afterinitial endoprotease cleavage during prohormone processing.Processes proinsulin. | Acts as guanine nucleotide exchange factor (GEF) forRHOA, RAC1 and CDC42 GTPases. Binding of APC may activate RAC1 GEFactivity. The APC-ARHGEF4 complex seems to be involved in cellmigration as well as in E-cadherin-mediated cell-cell adhesion.Required for MMP9 up-regulation via the JNK signaling pathway incolorectal tumor cells. Involved in tumor angiogenesis and mayplay a role in intestinal adenoma formation and tumor progression.{ECO:0000269|PubMed:10947987, ECO:0000269|PubMed:12598901,ECO:0000269|PubMed:17145773, ECO:0000269|PubMed:17599059,ECO:0000269|PubMed:19893577}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CPE_ARHGEF4 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CPE_ARHGEF4 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CPE | ROBO2, CHD3, GTF3C1, POLA2, POLDIP2, RPA1, UTP14A, MED31, LRIF1, PRKAA1, NUFIP1, SERPINB11, SIAE, RNASE13, PSG8, SLAMF1, SCGB1D1, PSG1 | ARHGEF4 | APC, RHOA, RAC1, HLA-B, KHDRBS1, MOV10, NXF1, TRIM25 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CPE_ARHGEF4 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | CPE | P16870 | DB00071 | Insulin Pork | Carboxypeptidase E | biotech | approved |
| Hgene | CPE | P16870 | DB00030 | Insulin Human | Carboxypeptidase E | biotech | approved|investigational |
Top |
RelatedDiseases for CPE_ARHGEF4 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CPE | C0028754 | Obesity | 2 | CTD_human |
| Hgene | CPE | C0014130 | Endocrine System Diseases | 1 | CTD_human |
| Hgene | CPE | C0021655 | Insulin Resistance | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|